Research synthesisHigh evidenceModerate effect4 studies · 4 beneficial · 0 neutral · 0 harmful
Across all 4 studies in the database, L-carnitine supplementation shows a consistent beneficial effect on reducing LDL cholesterol, with a moderate typical effect size. All 4 studies reported statistically significant improvements, and the median study duration across reporting studies was 56 days, indicating effects are typically observed at 6-10 weeks. The most-studied dose range is 50 mg/kg/day to 3000 mg/day, with evidence drawn mainly from clinical populations including women with PCOS, children on hemodialysis, and individuals with overweight/obesity or diabetes.
- Effective dose range: 50 mg/kg/day to 3000 mg/day
- Studied populations: women with PCOS, children on hemodialysis, adults with overweight/obesity, individuals with impaired glucose tolerance or diabetes
Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Evidence base is small (only 4 studies) — conclusions should be considered preliminary. The two randomized controlled trials had relatively small sample sizes (110 and 30 participants), and one study did not report a dose or duration, limiting dose-response precision.
Generated Jul 15, 2026